Most Terminal AIDS Patients Want to Be Revived if Their Heart Stops

Publication
Article
OncologyONCOLOGY Vol 10 No 9
Volume 10
Issue 9

For persons with AIDS, current health status does not necessarily affect their desire to be revived if their heart stops, according to a study supported by the Agency for Health Care Policy and Research (HS06239).

For persons with AIDS, current health status does not necessarilyaffect their desire to be revived if their heart stops, accordingto a study supported by the Agency for Health Care Policy andResearch (HS06239).

About 65% of terminally ill AIDS patients in this study, mostlyyoung homosexual and bisexual men, wanted to be revived if theirheart stopped. Overall, those who considered themselves to bein the best health were more likely to want to be revived. However,over half of those who considered their health to be the veryworst (the lowest quartile) also wanted to be resuscitated.

A key finding was that the relationship between health statusand desire for resuscitation does not hold up for all patients.For the third of patients who expressed the most reluctance togive up life, by saying that they wanted life extension even ifit meant living in some undesirable state (such as being blindor fed by a tube), current health status was unrelated to desirefor resuscitation.

These results suggest limits to the validity of assessing howa patient values his or her current health status by asking questionsthat involve loss or risk of life, such as "standard gambles"(for example, what risk the patient is willing to take of dyingin surgery to cure a health problem) and time trade-off questions(for example, how many years of later life a person is willingto give up for better life now). A general reluctance to giveup life may confound how patients answer such questions, notesArnold Epstein, md, of Harvard Medical School. These findingsare based on interviews of 291 patients with AIDS who participatedin the Boston Health Study during 1990 and 1991.

For more information, see "The Role of Reluctance to GiveUp Life in the Measurement of the Values of Health States,"by Floyd J. Fowler, Jr., phd, Paul D. Cleary, phd, Michael P.Massagli, phd, et al in Medical Decision Making [15(3):195-200,1995].

Related Videos
Domenica Lorusso, MD, PhD, says that paying attention to the quality of chemoradiotherapy is imperative to feeling confident about the potential addition of pembrolizumab for locally advanced cervical cancer.
Exercise and healthy lifestyles can lower the risk of cancer or the symptoms of cancer treatment despite having genetic dispositions, said Neil M. Iyengar, MD.
Cell therapy and vaccine approaches are among the several potential options for targeting KRAS in patients with KRAS G12C–mutated non–small cell lung cancer, says Sandip P. Patel, MD.
Marwan G. Fakih, MD, and Atif Hussein, MD, MMM, FACP, experts on colorectal cancer
A panel of 4 experts on multiple myeloma seated at a long table
A panel of 4 experts on multiple myeloma seated at a long table
Experts on MM
Related Content